1 / 6

OPIM 5894 Advanced Project management Vertex Pharmaceuticals case

OPIM 5894 Advanced Project management Vertex Pharmaceuticals case. TEAM 1. http://users.business.uconn.edu/snair/opim5894.html. Vertex Pharmaceuticals case. Which of the 4 project portfolio options currently facing Vertex do you favor? VX-765 Big money Earliest in development

nitza
Télécharger la présentation

OPIM 5894 Advanced Project management Vertex Pharmaceuticals case

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. OPIM 5894 Advanced Project managementVertex Pharmaceuticals case TEAM 1 http://users.business.uconn.edu/snair/opim5894.html

  2. Vertex Pharmaceuticals case • Which of the 4 project portfolio options currently facing Vertex do you favor? VX-765 • Big money • Earliest in development • Biggest risk Prof. Suresh Nair, University of Connecticut

  3. Vertex Pharmaceuticals case • Specifically, which two projects would you advance in development? Why? Show analysis. VX-702, VX-765 • Highest expected values • See graphs Prof. Suresh Nair, University of Connecticut

  4. Vertex Pharmaceuticals case Prof. Suresh Nair, University of Connecticut

  5. Vertex Pharmaceuticals case • Would you license out the two others not chosen or keep them as backup? • VX-148 – license out • VX-950 – license out • How much should Vertex management rely on quantitative methodologies (such as real option valuation) versus more qualitative approaches? • Quantitative Methodologies – 75% • Qualitative Approaches – 25% Prof. Suresh Nair, University of Connecticut

  6. Revenue Stream Prof. Suresh Nair, University of Connecticut

More Related